Alyeska Investment Group
CLB icon

Alyeska Investment Group’s Core Laboratories CLB Stock Holding History

Alyeska Investment Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-122,679
Closed -$18M – 491
2014
Q3 		$18M Buy
+122,679
New +$18.9M 0.37% 92

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group's CLB Position: Q4 2014 in Review

Alyeska Investment Group sold out of Core Laboratories (CLB) in Q4 2014, closing a stake of 122,679 shares — an estimated $18M sold.

Alyeska Investment Group first reported a position in CLB in Q3 2014 and held it in 1 quarter. The position peaked at $18M in Q3 2014. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • Alyeska Investment Group reported no remaining Core Laboratories position as of Q4 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 122,679 Core Laboratories shares in Q4 2014, an estimated $18M.
  • Alyeska Investment Group first reported a position in Core Laboratories in Q3 2014 and held it in 1 quarter.
  • Alyeska Investment Group's Core Laboratories position peaked at $18M in Q3 2014.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Alyeska Investment Group's 13F filing for Q4 2014, filed 17 Feb 2015.